Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
RMD Open
|
May 28, 2024
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study
Roy Fleischmann, Jerzy Swierkot, Sara K Penn, et al.
RMD Open
|
February 5, 2022
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study
Roy Fleischmann, Eduardo Mysler, Louis Bessette, et al.
Magnetic Resonance Imaging
|
May 4, 2004
Multispectral analysis of bone lesions in the hands of patients with rheumatoid arthritis
Richard A D Carano, John A Lynch, Janos Redei, et al.
The Journal of Rheumatology
|
September 3, 2015
The Longitudinal Reliability and Responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS)
Ida K Haugen, Iris Eshed, Frederique Gandjbakhch, et al.
The Journal of Rheumatology
|
September 3, 2011
Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience
Charles G Peterfy, Peter Countryman, Annarita Gabriele, et al.
European Radiology
|
January 6, 2005
Short tau inversion recovery and proton density-weighted fat suppressed sequences for the evaluation of osteoarthritis of the knee with a 1.0 T dedicated extremity MRI: development of a time-efficient sequence protocol
Frank W Roemer, Ali Guermazi, John A Lynch, et al.
The Journal of Rheumatology
|
September 3, 2011
The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) is reliable and sensitive to change: results from an OMERACT workshop
Pernille Bøyesen, Fiona M McQueen, Frédérique Gandjbakhch, et al.
Rheumatology (Oxford, England)
|
December 13, 2021
Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program
Charles G Peterfy, Vibeke Strand, Alan Friedman, et al.
Arthritis and Rheumatism
|
April 29, 2008
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
Stanley B Cohen, Robin K Dore, Nancy E Lane, et al.
RMD Open
|
March 14, 2018
Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS)
Féline P B Kroon, Charles G Peterfy, Philip G Conaghan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
RMD Open
|
May 28, 2024
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study
Roy Fleischmann, Jerzy Swierkot, Sara K Penn, et al.
RMD Open
|
February 5, 2022
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study
Roy Fleischmann, Eduardo Mysler, Louis Bessette, et al.
Magnetic Resonance Imaging
|
May 4, 2004
Multispectral analysis of bone lesions in the hands of patients with rheumatoid arthritis
Richard A D Carano, John A Lynch, Janos Redei, et al.
The Journal of Rheumatology
|
September 3, 2015
The Longitudinal Reliability and Responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS)
Ida K Haugen, Iris Eshed, Frederique Gandjbakhch, et al.
The Journal of Rheumatology
|
September 3, 2011
Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience
Charles G Peterfy, Peter Countryman, Annarita Gabriele, et al.
European Radiology
|
January 6, 2005
Short tau inversion recovery and proton density-weighted fat suppressed sequences for the evaluation of osteoarthritis of the knee with a 1.0 T dedicated extremity MRI: development of a time-efficient sequence protocol
Frank W Roemer, Ali Guermazi, John A Lynch, et al.
The Journal of Rheumatology
|
September 3, 2011
The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) is reliable and sensitive to change: results from an OMERACT workshop
Pernille Bøyesen, Fiona M McQueen, Frédérique Gandjbakhch, et al.
Rheumatology (Oxford, England)
|
December 13, 2021
Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program
Charles G Peterfy, Vibeke Strand, Alan Friedman, et al.
Arthritis and Rheumatism
|
April 29, 2008
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
Stanley B Cohen, Robin K Dore, Nancy E Lane, et al.
RMD Open
|
March 14, 2018
Atlas for the OMERACT thumb base osteoarthritis MRI scoring system (TOMS)
Féline P B Kroon, Charles G Peterfy, Philip G Conaghan, et al.
Page
of 3